HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
+7.04%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.01B
AUM Growth
+$3.01B
(+15%)
Cap. Flow
+$249M
Cap. Flow
% of AUM
8.25%
Top 10 Holdings %
Top 10 Hldgs %
29.79%
Holding
249
New
10
Increased
117
Reduced
112
Closed
8
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$67.1M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$50.7M |
| 3 |
Broadcom
AVGO
|
$43.9M |
| 4 |
Palo Alto Networks
PANW
|
$24.4M |
| 5 |
NVIDIA
NVDA
|
$22.7M |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$24M |
| 2 |
United Parcel Service
UPS
|
$14.4M |
| 3 |
Nike
NKE
|
$13.9M |
| 4 |
AbbVie
ABBV
|
$10.5M |
| 5 |
Intuitive Surgical
ISRG
|
$10.4M |
Sector Composition
| 1 | Healthcare | 39.8% |
| 2 | Technology | 19.93% |
| 3 | Financials | 5.73% |
| 4 | Communication Services | 3.7% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $270M | 8.96% |
2,753,709
+683,915
| +33% | +$67.1M |
|
|
2
iShares 7-10 Year Treasury Bond ETF
IEF
$35.7B
| $93.9M | 3.11% |
956,717
+516,428
| +117% | +$50.7M |
|
3
Eli Lilly
LLY
$657B
| $76.5M | 2.54% |
86,305
+20,146
| +30% | +$17.8M |
|
4
Johnson & Johnson
JNJ
$427B
| $76.2M | 2.53% |
469,974
-10,238
| -2% | -$1.66M |
|
5
UnitedHealth
UNH
$281B
| $74.1M | 2.46% |
126,790
-12,862
| -9% | -$7.52M |
|
6
Boston Scientific
BSX
$156B
| $62.9M | 2.09% |
750,216
+54,371
| +8% | +$4.56M |
|
7
Medtronic
MDT
$119B
| $62M | 2.06% |
689,131
+42,112
| +7% | +$3.79M |
|
8
Bristol-Myers Squibb
BMY
$96B
| $61.2M | 2.03% |
1,182,198
-56,795
| -5% | -$2.94M |
|
9
Stryker
SYK
$150B
| $61M | 2.03% |
168,984
+16,194
| +11% | +$5.85M |
|
10
Abbott
ABT
$231B
| $60.1M | 1.99% |
527,132
+38,660
| +8% | +$4.41M |
|
11
Zoetis
ZTS
$69.3B
| $59.8M | 1.98% |
306,100
-31,617
| -9% | -$6.18M |
|
12
Vanguard Long-Term Treasury ETF
VGLT
$9.84B
| $59.6M | 1.98% |
968,913
+226,976
| +31% | +$14M |
|
13
Novartis
NVS
$245B
| $57.3M | 1.9% |
498,263
-19,676
| -4% | -$2.26M |
|
14
Merck
MRK
$210B
| $56.8M | 1.88% |
499,908
+79,662
| +19% | +$9.05M |
|
15
AstraZeneca
AZN
$248B
| $56.7M | 1.88% |
728,187
+21,514
| +3% | +$1.68M |
|
16
Thermo Fisher Scientific
TMO
$186B
| $56.6M | 1.88% |
91,540
+583
| +0.6% | +$361K |
|
17
Danaher
DHR
$147B
| $56.2M | 1.87% |
202,263
+2,465
| +1% | +$685K |
|
18
Agilent Technologies
A
$35.7B
| $55.7M | 1.85% |
374,920
-6,490
| -2% | -$964K |
|
19
Amgen
AMGN
$155B
| $55.2M | 1.83% |
171,339
-15,004
| -8% | -$4.83M |
|
|
20
AbbVie
ABBV
$372B
| $54M | 1.79% |
273,211
-53,058
| -16% | -$10.5M |
|
21
Elevance Health
ELV
$71.8B
| $53.7M | 1.78% |
103,188
+6,115
| +6% | +$3.18M |
|
22
Microsoft
MSFT
$3.77T
| $53.5M | 1.78% |
124,415
+31,878
| +34% | +$13.7M |
|
|
23
NVIDIA
NVDA
$4.24T
| $51.3M | 1.7% |
422,225
+186,929
| +79% | +$22.7M |
|
|
24
Intuitive Surgical
ISRG
$170B
| $50.9M | 1.69% |
103,698
-21,174
| -17% | -$10.4M |
|
|
25
Broadcom
AVGO
$1.4T
| $46.6M | 1.55% |
270,240
+254,732
| +1,643% | +$43.9M |
|